27 FEBRUARY, 2019 Dr. Susan Alpert, MD, PhD, Joins Cognos Therapeutics as Lead Regulatory Consultant Dr. Susan Alpert, MD, PhD, has been named Lead Regulatory Consultant for Cognos Therapeutics, Inc. Dr. Alpert is considered one of the top U.S. regulatory experts....
11 JANUARY, 2018 Cognos’ SINNAIS Smart Implantable Pump has potential to Improve CAR T Cell Efficacy in Solid Tumors Cognos Therapeutics (Cognos Thx) is exploring the potential of using its SINNAIS implantable pump as the delivery mechanism for a new drug...
13 JULY, 2017 Cognos Therapeutics plans to conduct a twenty-patient human clinical trial using direct delivery of Herceptin (a Genentech drug) to prove drug safety in the brain region. Cognos Therapeutics (Cognos Thx) plans to use Herceptin, a Genentech drug, to be...
Dr. Ali-Osman on future of cancer treatment 16 SEPT, 2016 Dr. Francis Ali-Osman Discusses Future of Cancer Treatment On September 16, 2016 Dr. Francis Ali-Osman was asked to speak at the Hancock Symposium at Westminster Collage on the state of cancer research and...
31 MAR, 2015 FDA’s Role In The Precision Medicine Initiative Pushes Combination Drug Devices to New Heights Sharing Cognos Therapeutics’ Vision. Most medical treatments are designed for the “average patient” as a “one-size-fits-all approach”,...
Recent Comments